HCXYNYSEUS GAAP · USD

Hercules Capital, Inc.

Hercules Capital, Inc. is a specialty finance company that provides senior secured loans and structured debt to venture capital-backed and institutional-backed companies. Its portfolio is concentrated in technology and life sciences businesses, and it also earns fees and investment returns through warrants, equity interests, and advisory services via its subsidiary platform.

Net income340m USD
+29.2 %y/y
Free cash flow-426m USD
−260.6 %y/y

Fiscal year 2025 · change from previous year

Development 2020–2025

01m USD202020212022202320242025
RevenueOperating profit (EBIT)
Ask Clarifo about Hercules Capital, Inc.

Business

Share of revenue
Senior secured loans70 %

First-lien and other senior debt investments to growth-stage portfolio companies.

Structured debt15 %

Debt instruments paired with warrants, options, or conversion features.

Fee income10 %

Commitment, facility, and other origination-related fees recognized over time.

Equity and warrant income3 %

Dividends and realized/unrealized gains from equity-linked investments.

Advisory and management services2 %

Asset-based advisory fees from third-party investment vehicles managed by the Adviser Subsidiary.

Customers

Hercules Capital lends primarily to venture capital-backed and institutional-backed companies that need growth capital without giving up as much dilution as an equity round. Its core end markets are technology and life sciences, especially software, semiconductors, networking, medtech, biopharma, and related innovation-driven businesses. The Adviser Subsidiary also serves external investors in privately offered funds through investment management agreements.

Venture capital-backed technology companies

Borrowers in software, hardware, networking, semiconductors, and IT services that use venture debt to extend runway and fund growth.

Life sciences companies

Medical device, biopharma, drug discovery, and healthcare information companies that need capital for development and commercialization.

Institutional-backed growth companies

Later-stage private companies backed by institutional investors that want senior secured financing with flexible terms.

Third-party fund investors

External parties investing in Adviser Funds managed by the Adviser Subsidiary for private credit exposure.

Strategy

The company’s strategy is to grow net investment income and NAV by originating senior secured and structured debt in technology-related and life sciences companies. It also expands fee-based earnings through the Adviser Subsidiary, while using equity raises, debt facilities, securitizations, and SBIC borrowing to fund new investments and manage liquidity.

Originate senior secured loans in technology and life sciencesShort term

This is the core earnings engine and the main source of recurring interest income.

Grow fee-based advisory assetsMedium term

Management fees diversify revenue beyond portfolio interest income and improve scalability.

Maintain flexible funding capacityShort term

Access to equity, debt, and SBIC leverage supports portfolio growth and liquidity management.

Geography

Hercules Capital is headquartered in San Mateo, California and operates additional offices in Boston, New York, Denver, Westport, San Diego, and London. The business is primarily U.S.-focused, but the London office supports international sourcing and portfolio relationships, while the company remains exposed to U.S. capital markets and the broader venture ecosystem.

Risks

Hercules Capital is exposed to credit risk, valuation risk, and competition because it lends to private growth companies whose operating performance can change quickly. As a BDC and RIC, it also faces regulatory constraints, funding-market sensitivity, and the risk that portfolio marks or borrower stress could reduce NAV and distributable income.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Credit deterioration in venture-backed borrowers1Fair value volatility of debt investments2Funding and liquidity risk3Regulatory constraints under the BDC structure4Competitive pressure in venture debt5
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Credit deterioration in venture-backed borrowersImpact: HighLikelihood: High

    The portfolio is concentrated in private growth companies with limited operating history and higher failure rates.

    Exposure: Senior secured loans and structured debt to technology and life sciences companies

  2. Fair value volatility of debt investmentsImpact: HighLikelihood: High

    Valuations depend heavily on yield assumptions and portfolio company performance, which can change quickly.

    Exposure: Debt investment marks and NAV

  3. Funding and liquidity riskImpact: HighLikelihood: Medium

    The business relies on debt facilities, equity issuance, and portfolio repayments to fund new originations.

    ExposureCredit facilitiesATM issuanceSBIC borrowing
  4. Regulatory constraints under the BDC structureImpact: MediumLikelihood: Medium

    1940 Act and RIC rules can restrict leverage, distributions, and investment flexibility.

    Exposure: Capital allocation and operating flexibility

  5. Competitive pressure in venture debtImpact: MediumLikelihood: Medium

    Banks, non-bank lenders, and venture funds compete for the same high-quality borrowers.

    Exposure: Origination volume and pricing

Accounting

Judgemental items
Fair value of debt investments

Management uses yield-based valuation estimates that can materially change unrealized gains or losses.

Impact: Directly affects NAV and reported investment income

Income recognition on loans and fees

Interest and fee timing depends on contractual terms and expected collectability.

Impact: Affects recurring revenue and quarter-to-quarter comparability

Valuation of warrants and equity investments

These instruments are harder to price and can create volatile unrealized results.

Impact: Can swing earnings when marks change or positions are realized

Income taxes

Tax treatment of investment income, gains, and subsidiary structures requires judgment.

Impact: Affects net income available to shareholders

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026

Hercules Capital, Inc. (NYSE) – Financial Analysis & Key Metrics – Clarifo